Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis

BackgroundBreast cancer, particularly triple-negative (TNBC), is a leading malignancy with aggressive traits and high metastasis rates. Clinical trial is an important tool for optimizing therapeutic strategies in the evaluation of the safety and efficacy for TNBC. Our bibliometric study of TNBC clin...

Full description

Bibliographic Details
Main Authors: Qi Xu, Xiaoyu Feng, Siyuan Qin, Yu Hong, Rui Cui, Jia Liang, Zhuya Xiao, Yuan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-10-01
Series:Frontiers in Oncology
Subjects:
bibliometric analysis
TNBC
clinical trial
neoadjuvant therapy
antibody drug conjugates
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1423924/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1423924/full

Similar Items